Biotage moves to 100% direct sales for SPE products in the UK

Biotage moves to 100% direct sales for SPE products in the UK

Biotage is expanding its direct sales coverage and will begin selling SPE
products directly into non-pharma application areas within the UK starting
January 18, 2010.  Sales to non-pharmaceutical based markets and customers have
previously been managed by a distributor.

Biotage ISOLUTE® and EVOLUTE® sample preparation products are available in a
variety of media types and formats for bioanalytical, forensic, environmental
and agrochemical/food applications. The company continues to broaden its product
line and application scope as part of a focused growth strategy.  Most recently
Biotage introduced the innovative ISOLUTE SLE+ supported-liquid extraction
product line as a faster, cleaner and cost effective alternative to the
traditional and more complicated extraction techniques.

“This is a logical step for Biotage. Many applications for our products exist
beyond the biopharmaceutical market, where Biotage has focused historically.  We
are now actively seeking to broaden our customer base and this is one of the
routes we will exploit. SPE is a product area in which Biotage has great
knowledge and experience. This is something we are going to take advantage of
going forward.“ says Torben Jørgensen, CEO.

“Our strategy to invest more heavily in the sample prep area and the expansion
of direct sales in the UK has excited our Marketing and Sales teams. The Sample
Prep market is growing and we feel we have excellent technology and potential to
grow our market share. This move is important for us as it enables us to get
closer to our customers in the UK market at the same time as we are venturing
into new customer segments.“ says Scott Carr, VP of Commercial Operations.

Contact:								
Torben Jørgensen, President and CEO				
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com     

About Biotage 
Biotage offers solutions, knowledge and experience in the areas of analytical
and medicinal chemistry. The customers include the world's top pharma and
biotech companies, as well as leading academic institutes. The company is
headquartered in Uppsala, Sweden, and has offices in the United States, United
Kingdom and Japan. Biotage has 270 employees and had sales of SEK 385,3m in
2008. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website:
www.biotage.com